New Enterprise Associates 16, L.P. is > 10% Shareholder of Akouos, Inc.. Currently has a direct ownership of 0 shares of AKUS, which is worth approximately $0. The most recent transaction as insider was on Nov 30, 2022, when has been sold 4,294,207 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

New Enterprise Associates 16, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2022
SELL
Disposition due to a tender of shares in a change of control transaction
-
4,294,207 Reduced 100.0%
0 Common Stock

Also insider at

BHG
Bright Health Group Inc. Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
MTCR
Metacrine, Inc. Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
NEA

New Enterprise Associates 16, L.P.

> 10% Shareholder
Timonium, MD

Track Institutional and Insider Activities on AKUS

Follow Akouos, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKUS shares.

Notify only if

Insider Trading

Get notified when an Akouos, Inc. insider buys or sells AKUS shares.

Notify only if

News

Receive news related to Akouos, Inc.

Track Activities on AKUS